Nutrient, Neural and Endocrine Control of Glucagon-like Peptide Secretion

 

 Buy Article Permissions and Reprints

Abstract

The intestinal glucagon-like peptides, GLP-1 and GLP-2, are important regulators of nutrient intake, digestion, absorption and metabolism. Extensive studies have shown that the co-secretion of GLP-1 and GLP-2 is regulated by a variety of dietary nutrient, neural and endocrine inputs. Furthermore, secretion of these peptides is altered in a number of pathological conditions, including type 2 diabetes and obesity. The purpose of this review is to discuss the regulation of GLP-1 and GLP-2 secretion in both health and disease.

References

• 1 Drucker D J. Biological actions and therapeutic potential of the glucagon-like peptides.  Gastroenterology. 2002;  122 531-544
  PubMedGoogle Scholar
• 2 Vilsboll T, Krarup T, Deacon C F, Madsbad S, Holst J J. Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients.  Diabetes. 2001;  50 609-613
  PubMedGoogle Scholar
• 3 Rask E, Olsson T, Soderberg S, Johnson O, Seckl J, Holst J J, Ahren B. Impaired incretin response after a mixed meal is associated with insulin resistance in nondiabetic men.  Diabetes Care. 2001;  24 1640-1645
  CrossrefPubMedGoogle Scholar
• 4 Ranganath L R, Beety J M, Morgan L M, Wright J W, Howland R, Marks V. Attenuated GLP-1 secretion in obesity: cause or consequence?.  Gut. 1996;  38 916-919
  PubMedGoogle Scholar
• 5 Xiao Q, Boushey R P, Cino M, Drucker D J, Brubaker P L. Circulating levels of glucagon-like peptide-2 in human subjects with inflammatory bowel disease.  Am J Physiol Regul Integr Comp Physiol. 2000;  278 R1057-1063
  PubMedGoogle Scholar
• 6 Jeppesen P B, Hartmann B, Hansen B S, Thulesen J, Holst J J, Mortensen P B. Impaired meal stimulated glucagon-like peptide 2 response in ileal resected short bowel patients with intestinal failure.  Gut. 1999;  45 559-563
  PubMedGoogle Scholar
• 7 Eissele R, Goke R, Willemer S, Harthus H P, Vermeer H, Arnold R, Goke B. Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man.  Eur J Clin Invest. 1992;  22 283-291
  CrossrefPubMedGoogle Scholar
• 8 Kervran A, Blache P, Bataille D. Distribution of oxyntomodulin and glucagon in the gastrointestinal tract and the plasma of the rat.  Endocrinology. 1987;  121 704-713
  PubMedGoogle Scholar
• 9 Orskov C, Holst J J. Radio-immunoassays for glucagon-like peptides 1 and 2 (GLP-1 and GLP-2).  Scand J Clin Lab Invest. 1987;  47 165-174
  PubMedGoogle Scholar
• 10 Drucker D J, Jin T, Asa S L, Young T A, Brubaker P L. Activation of proglucagon gene transcription by protein kinase-A in a novel mouse enteroendocrine cell line.  Mol Endocrinol. 1994;  8 1646-1655
  CrossrefPubMedGoogle Scholar
• 11 Reimer R A, Darimont C, Gremlich S, Nicolas-Metral V, Ruegg U T, Mace K. A human cellular model for studying the regulation of glucagon-like peptide-1 secretion.  Endocrinology. 2001;  142 4522-4528
  CrossrefPubMedGoogle Scholar
• 12 Elliott R M, Morgan L M, Tredger J A, Deacon S, Wright J, Marks V. Glucagon-like peptide-1 (7 - 36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns.  J Endocrinol. 1993;  138 159-166
  PubMedGoogle Scholar
• 13 Xiao Q, Boushey R P, Drucker D J, Brubaker P L. Secretion of the intestinotropic hormone glucagon-like peptide 2 is differentially regulated by nutrients in humans.  Gastroenterology. 1999;  117 99-105
  PubMedGoogle Scholar
• 14 Burrin D G, Stoll B, Jiang R, Chang X, Hartmann B, Holst J J, Greeley G H Jr, Reeds P J. Minimal enteral nutrient requirements for intestinal growth in neonatal piglets: how much is enough?.  Am J Clin Nutr. 2000;  71 1603-1610
  PubMedGoogle Scholar
• 15 Schirra J, Katschinski M, Weidmann C, Schafer T, Wank U, Arnold R, Goke B. Gastric emptying and release of incretin hormones after glucose ingestion in humans.  J Clin Invest. 1996;  97 92-103
  CrossrefPubMedGoogle Scholar
• 16 Kreymann B, Williams G, Ghatei M A, Bloom S R. Glucagon-like peptide-1 7 - 36: a physiological incretin in man.  Lancet. 1987;  2 1300-1304
  PubMedGoogle Scholar
• 17 Balks H J, Holst J J, von zur Muhlen A, Brabant G. Rapid oscillations in plasma glucagon-like peptide-1 (GLP-1) in humans: cholinergic control of GLP-1 secretion via muscarinic receptors.  J Clin Endocrinol Metab. 1997;  82 786-790
  CrossrefPubMedGoogle Scholar
• 18 Unger R H, Ohneda A, Valverde I, Eisentraut A M, Exton J. Characterization of the responses of circulating glucagon-like immunoreactivity to intraduodenal and intravenous administration of glucose.  J Clin Invest. 1968;  47 48-65
  PubMedGoogle Scholar
• 19 Kong M F, Chapman I, Goble E, Wishart J, Wittert G, Morris H, Horowitz M. Effects of oral fructose and glucose on plasma GLP-1 and appetite in normal subjects.  Peptides. 1999;  20 545-551
  CrossrefPubMedGoogle Scholar
• 20 Qualmann C, Nauck M A, Holst J J, Orskov C, Creutzfeldt W. Glucagon-like peptide 1 (7 - 36)amide secretion in response to luminal sucrose from the upper and lower gut. A study using alpha-glucosidase inhibition (acarbose).  Scand J Gastroenterol. 1995;  30 892-896
  CrossrefPubMedGoogle Scholar
• 21 Damholt A B, Buchan A M, Kofod H. Glucagon-like-peptide-1 secretion from canine L-cells is increased by glucose-dependent-insulinotropic peptide but unaffected by glucose.  Endocrinology. 1998;  139 2085-2091
  CrossrefPubMedGoogle Scholar
• 22 Plaisancie P, Dumoulin V, Chayvialle J A, Cuber J C. Luminal glucagon-like peptide-1 (7 - 36)amide-releasing factors in the isolated vascularly perfused rat colon.  J Endocrinol. 1995;  145 521-526
  PubMedGoogle Scholar
• 23 Brubaker P L. Regulation of intestinal proglucagon-derived peptide secretion by intestinal regulatory peptides.  Endocrinology. 1991;  128 3175-3182
  PubMedGoogle Scholar
• 24 Roberge J N, Brubaker P L. Regulation of intestinal proglucagon-derived peptide secretion by glucose-dependent insulinotropic peptide in a novel enteroendocrine loop.  Endocrinology. 1993;  133 233-240
  CrossrefPubMedGoogle Scholar
• 25 Ferraris R P, Yasharpour S, Lloyd K C, Mirzayan R, Diamond J M. Luminal glucose concentrations in the gut under normal conditions.  Am J Physiol. 1990;  259 G822-837
  PubMedGoogle Scholar
• 26 Hansen L, Hartmann B, Mineo H, Holst J J. Glucagon-like peptide-1 secretion is influenced by perfusate glucose concentration and by a feedback mechanism involving somatostatin in isolated perfused porcine ileum.  Regul Pept. 2004;  118 11-18
  CrossrefPubMedGoogle Scholar
• 27 Reimann F, Gribble F M. Glucose-sensing in glucagon-like peptide-1-secreting cells.  Diabetes. 2002;  51 2757-2763
  PubMedGoogle Scholar
• 28 Gribble F M, Williams L, Simpson A K, Reimann F. A novel glucose-sensing mechanism contributing to glucagon-like peptide-1 secretion from the GLUTag cell line.  Diabetes. 2003;  52 1147-1154
  CrossrefPubMedGoogle Scholar
• 29 Sasaki H, Manaka H, Yamatani K, Tominaga M. GLP-1 secretion coupled with Na/glucose transporter from the isolated perfused canine ileum.  Digestion. 1993;  54 365-367
  PubMedGoogle Scholar
• 30 Ritzel U, Fromme A, Ottleben M, Leonhardt U, Ramadori G. Release of glucagon-like peptide-1 (GLP-1) by carbohydrates in the perfused rat ileum.  Acta Diabetol. 1997;  34 18-21
  CrossrefPubMedGoogle Scholar
• 31 Damci T, Yalin S, Balci H, Osar Z, Korugan U, Ozyazar M, Ilkova H. Orlistat augments postprandial increases in glucagon-like peptide 1 in obese type 2 diabetic patients.  Diabetes Care. 2004;  27 1077-1080
  PubMedGoogle Scholar
• 32 Ranganath L, Norris F, Morgan L, Wright J, Marks V. Inhibition of carbohydrate-mediated glucagon-like peptide-1 (7 - 36)amide secretion by circulating non-esterified fatty acids.  Clin Sci (Lond). 1999;  96 335-342
  PubMedGoogle Scholar
• 33 Rocca A S, Brubaker P L. Stereospecific effects of fatty acids on proglucagon-derived peptide secretion in foetal rat intestinal cultures.  Endocrinology. 1995;  136 5593-5599
  CrossrefPubMedGoogle Scholar
• 34 Rocca A S, LaGreca J, Kalitsky J, Brubaker P L. Monounsaturated fatty acid diets improve glycemic tolerance through increased secretion of glucagon-like peptide-1.  Endocrinology. 2001;  142 1148-1155
  CrossrefPubMedGoogle Scholar
• 35 Adrian T E, Ballantyne G H, Longo W E, Bilchik A J, Graham S, Basson M D, Tierney R P, Modlin I M. Deoxycholate is an important releaser of peptide YY and enteroglucagon from the human colon.  Gut. 1993;  34 1219-1224
  PubMedGoogle Scholar
• 36 Dumoulin V, Moro F, Barcelo A, Dakka T, Cuber J C. Peptide YY, glucagon-like peptide-1, and neurotensin responses to luminal factors in the isolated vascularly perfused rat ileum.  Endocrinology. 1998;  139 3780-3786
  CrossrefPubMedGoogle Scholar
• 37 Borgstrom B, Dahlqvist A, Lundh G, Sjovall J. Studies of intestinal digestion and absorption in the human.  J Clin Invest. 1957;  36 1521-1536
  PubMedGoogle Scholar
• 38 Fu-Cheng X, Anini Y, Chariot J, Castex N, Galmiche J P, Roze C. Mechanisms of peptide YY release induced by an intraduodenal meal in rats: neural regulation by proximal gut.  Pflugers Arch. 1997;  433 571-579
  PubMedGoogle Scholar
• 39 Roberge J N, Brubaker P L. Secretion of proglucagon-derived peptides in response to intestinal luminal nutrients.  Endocrinology. 1991;  128 3169-3174
  PubMedGoogle Scholar
• 40 Roberge J N, Gronau K A, Brubaker P L. Gastrin-releasing peptide is a novel mediator of proximal nutrient-induced proglucagon-derived peptide secretion from the distal gut.  Endocrinology. 1996;  137 2383-2388
  CrossrefPubMedGoogle Scholar
• 41 Miyashita T, Hashimoto T, Gomez G, Townsend C M Jr, Greeley G H Jr, Thompson J C. Neurotensin secretion in response to intraduodenal and intraileal administration of fat in dogs.  Biol Signals. 1992;  1 275-281
  PubMedGoogle Scholar
• 42 Rocca A S, Brubaker P L. Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion.  Endocrinology. 1999;  140 1687-1694
  CrossrefPubMedGoogle Scholar
• 43 Anini Y, Hansotia T, Brubaker P L. Muscarinic receptors control postprandial release of glucagon-like peptide-1: in vivo and in vitro studies in rats.  Endocrinology. 2002;  143 2420-2426
  CrossrefPubMedGoogle Scholar
• 44 Anini Y, Brubaker P L. Muscarinic receptors control glucagon-like peptide 1 secretion by human endocrine L-cells.  Endocrinology. 2003;  144 3244-3250
  CrossrefPubMedGoogle Scholar
• 45 Berthoud H R, Carlson N R, Powley T L. Topography of efferent vagal innervation of the rat gastrointestinal tract.  Am J Physiol. 1991;  260 R200-207
  PubMedGoogle Scholar
• 46 Berthoud H R, Kressel M, Raybould H E, Neuhuber W L. Vagal sensors in the rat duodenal mucosa: distribution and structure as revealed by in vivo DiI-tracing.  Anat Embryol (Berl). 1995;  191 203-212
  PubMedGoogle Scholar
• 47 Claustre J, Brechet S, Plaisancie P, Chayvialle J A, Cuber J C. Stimulatory effect of beta-adrenergic agonists on ileal L-cell secretion and modulation by alpha-adrenergic activation.  J Endocrinol. 1999;  162 271-278
  CrossrefPubMedGoogle Scholar
• 48 Dumoulin V, Dakka T, Plaisancie P, Chayvialle J A, Cuber J C. Regulation of glucagon-like peptide-1-(7 - 36)amide, peptide YY, and neurotensin secretion by neurotransmitters and gut hormones in the isolated vascularly perfused rat ileum.  Endocrinology. 1995;  136 5182-5188
  CrossrefPubMedGoogle Scholar
• 49 Orskov C, Holst J J, Knuhtsen S, Baldissera F G, Poulsen S S, Nielsen O V. Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas.  Endocrinology. 1986;  119 1467-1475
  PubMedGoogle Scholar
• 50 Herrmann-Rinke C, Voge A, Hess M, Goke B. Regulation of glucagon-like peptide-1 secretion from rat ileum by neurotransmitters and peptides.  J Endocrinol. 1995;  147 25-31
  PubMedGoogle Scholar
• 51 Persson K, Gingerich R L, Nayak S, Wada K, Wada E, Ahren B. Reduced GLP-1 and insulin responses and glucose intolerance after gastric glucose in GRP receptor-deleted mice.  Am J Physiol Endocrinol Metab. 2000;  279 E956-962
  PubMedGoogle Scholar
• 52 Tseng C C, Kieffer T J, Jarboe L A, Usdin T B, Wolfe M M. Postprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP). Effect of a specific glucose-dependent insulinotropic polypeptide receptor antagonist in the rat.  J Clin Invest. 1996;  98 2440-2445
  PubMedGoogle Scholar
• 53 Nauck M A, Bartels E, Orskov C, Ebert R, Creutzfeldt W. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7 - 36)amide infused at near-physiological insulinotropic hormone and glucose concentrations.  J Clin Endocrinol Metab. 1993;  76 912-917
  CrossrefPubMedGoogle Scholar
• 54 Miyawaki K, Yamada Y, Yano H, Niwa H, Ban N, Ihara Y, Kubota A, Fujimoto S, Kajikawa M, Kuroe A, Tsuda K, Hashimoto H, Yamashita T, Jomori T, Tashiro F, Miyazaki J, Seino Y. Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice.  Proc Natl Acad Sci U S A. 1999;  96 14 843-14 847
  PubMedGoogle Scholar
• 55 Anini Y, Brubaker P L. Role of leptin in the regulation of glucagon-like peptide-1 secretion.  Diabetes. 2003;  52 252-259
  PubMedGoogle Scholar
• 56 Vilsboll T, Agerso H, Krarup T, Holst J J. Similar elimination rates of glucagon-like peptide-1 in obese type 2 diabetic patients and healthy subjects.  J Clin Endocrinol Metab. 2003;  88 220-224
  CrossrefPubMedGoogle Scholar
• 57 Brubaker P L, Drucker D J, Greenberg G R. Synthesis and secretion of somatostatin-28 and -14 by foetal rat intestinaL-cells in culture.  Am J Physiol. 1990;  258 G974-981
  PubMedGoogle Scholar
• 58 Hansen L, Hartmann B, Bisgaard T, Mineo H, Jorgensen P N, Holst J J. Somatostatin restrains the secretion of glucagon-like peptide-1 and -2 from isolated perfused porcine ileum.  Am J Physiol Endocrinol Metab. 2000;  278 E1010-1018
  PubMedGoogle Scholar
• 59 Jia X, Brown J C, Kwok Y N, Pederson R A, McIntosh C H. Gastric inhibitory polypeptide and glucagon-like peptide-1(7 - 36)amide exert similar effects on somatostatin secretion but opposite effects on gastrin secretion from the rat stomach.  Can J Physiol Pharmacol. 1994;  72 1215-1219
  PubMedGoogle Scholar
• 60 Brubaker P L, Efendic S, Greenberg G R. Truncated and full-length glucagon-like peptide-1 (GLP-1) differentially stimulate intestinal somatostatin release.  Endocrine. 1997;  6 91-95
  PubMedGoogle Scholar

Dr. P. L. Brubaker

Department of Physiology

Room 3366 · Medical Sciences Building · University of Toronto · 1 King’s College Circle · Toronto · ON M5S 1A8 Canada

Phone: + 1(416)978-2593

Fax: + 1(416)978-2593 ·

Email: p.brubaker@utoronto.ca